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Structural determinants at the M2 
muscarinic receptor modulate the 
RGS4-GIRK response to pilocarpine 
by impairment of the receptor 
voltage sensitivity
I-Shan Chen1, Kazuharu Furutani1,2 & Yoshihisa Kurachi1,2
Membrane potential controls the response of the M2 muscarinic receptor to its ligands. Membrane 
hyperpolarization increases response to the full agonist acetylcholine (ACh) while decreasing response 
to the partial agonist pilocarpine. We previously have demonstrated that the regulator of G-protein 
signaling (RGS) 4 protein discriminates between the voltage-dependent responses of ACh and 
pilocarpine; however, the underlying mechanism remains unclear. Here we show that RGS4 is involved 
in the voltage-dependent behavior of the M2 muscarinic receptor-mediated signaling in response 
to pilocarpine. Additionally we revealed structural determinants on the M2 muscarinic receptor 
underlying the voltage-dependent response. By electrophysiological recording in Xenopus oocytes 
expressing M2 muscarinic receptor and G-protein-gated inwardly rectifying K+ channels, we quantified 
voltage-dependent desensitization of pilocarpine-induced current in the presence or absence of 
RGS4. Hyperpolarization-induced desensitization of the current required for RGS4, also depended on 
pilocarpine concentration. Mutations of charged residues in the aspartic acid-arginine-tyrosine motif of 
the M2 muscarinic receptor, but not intracellular loop 3, significantly impaired the voltage-dependence 
of RGS4 function. Thus, our results demonstrated that voltage-dependence of RGS4 modulation is 
derived from the M2 muscarinic receptor. These results provide novel insights into how membrane 
potential impacts G-protein signaling by modulating GPCR communication with downstream effectors.
Membrane potential controls physiological events through regulating a variety of protein functions, including 
modulation of ligand binding and signal transduction in G-protein-coupled receptors (GPCRs)1–5. The M2 
muscarinic receptor is the one of the most intensively studied GPCRs in its voltage-dependent behaviors and 
molecular mechanisms1–4, 6–12. For example, membrane hyperpolarization increases the affinity of the M2 mus-
carinic receptor for its native full agonist, acetylcholine (ACh), and decreases affinity for its partial agonist pilo-
carpine3, 9, 10. Conversely, pilocarpine binding enhances the voltage-induced conformational change of the M2 
muscarinic receptor, while ACh binding immobilizes the charge movement4. Therefore, access to some confor-
mational states of the M2 muscarinic receptor is thought to be dependent on the binding of specific agonists, and 
membrane potential modulates the transition between these conformational states2, 10, 11, 13. However, how the 
voltage-dependent states stabilized by different agonists regulate cellular responses is not well understood.
One of the important regions for the voltage-dependent behavior of M2 muscarinic receptor toward its ago-
nist is intracellular loop 3, which is also the key motif responsible for G-protein interaction3, 12, 14, 15. Mutation 
of amino acid residues KKDKK located in the N-terminal region of intracellular loop 3 to the sequence ELAAL 
abolish the voltage-dependence of ACh binding3, 12. The aspartic acid-arginine-tyrosine (DRY) motif of the M2 
muscarinic receptor could also be an important region for its voltage-sensitivity3. The DRY motif is critical for 
regulating GPCR conformational states and agonist-induced response6, 14, 16, 17. Neutralization of D1203.49 and 
1Department of Pharmacology, Graduate School of Medicine, Osaka University, Suita, Osaka, 565-0871, Japan. 2Global 
Center for Medical Engineering and Informatics, Osaka University, Suita, Osaka, 565-0871, Japan. Correspondence 
and requests for materials should be addressed to K.F. (email: furutani@pharma2.med.osaka-u.ac.jp) or 
 Y.K. (email: ykurachi@pharma2.med.osaka-u.ac.jp)
Received: 16 January 2017
Accepted: 24 May 2017
Published online: 21 July 2017
OPEN
www.nature.com/scientificreports/
2Scientific RepoRts | 7: 6110 | DOI:10.1038/s41598-017-05128-z
R1213.50 (D120N/R121N mutant) in the DRY motif has been proposed to abolish the charge movement of the M2 
muscarinic receptor3. However, another study concluded that gating current still occurs in the D120N/R121N 
mutant and therefore these residues are not the key motif responsible for voltage sensor4. Therefore, it remains 
controversial whether the DRY motif acts as a voltage sensor or not1, 7. There is also no evidence whether the 
voltage sensor function of the M2 muscarinic receptor via DRY motif or the intracellular loop 3 can regulate its 
downstream G-protein signaling regulators.
We previously revealed that the regulator of G-protein signaling (RGS) 4 protein modulates the cellular effi-
cacy of pilocarpine18. RGS proteins are known to negatively regulate G-protein signaling by accelerating GTP 
hydrolysis to GDP by Gα subunit and thereby terminating the G-protein signal19–23. Pilocarpine promotes 
the RGS4-mediated inhibition of M2 muscarinic receptor-activated G-protein signaling, leading to a smaller 
G-protein-gated inwardly rectifying K+ (GIRK) current than that of ACh18. Importantly, membrane potential 
controls this phenomenon18. However, how RGS4 is involved in the voltage-dependent behavior of M2 mus-
carinic receptor-activated signaling remains unclear.
Since RGS4 is not a membrane protein, RGS4 seems unlikely to function as a voltage sensor. This suggests the 
voltage sensitivity of RGS4 is derived from its coupled membrane protein, M2 muscarinic receptor. If so, the M2 
muscarinic receptor would act as a voltage sensor not only toward its agonists but also toward the RGS4. The DRY 
motif and the intracellular loop 3 at the M2 muscarinic receptor are candidates for the structural determinants 
which contribute to the voltage-dependence of RGS4.
Here, we characterized the voltage-dependence of RGS4 modulation on M2 muscarinic receptor-activated 
signaling and revealed which receptor motif contributes to the underlying mechanism. With electrophysiologi-
cal recordings from Xenopus oocytes, we demonstrate that RGS4 triggers a voltage-dependent current decay of 
pilocarpine-induced GIRK current. By structure-function analysis of the DRY motif and the intracellular loop 
3 of M2 muscarinic receptor using mutagenesis methods, we observed that mutations of charged residues in the 
DRY motif (D1203.49 and R1213.50), instead of intracellular loop 3, significantly impaired the voltage-dependence 
of RGS4 modulation. The results demonstrate a novel mechanism that membrane potential modulates RGS4 
function through the voltage-sensitive M2 muscarinic receptor.
Results
RGS4 modulation of M2 muscarinic receptor-mediated GIRK currents by pilocarpine is volt-
age-dependent. To understand the effects of membrane potential on RGS4 function, we recorded the M2 
muscarinic receptor-activated GIRK currents in rat atrial myocytes and Xenopus oocytes heterologously express-
ing the M2 muscarinic receptor, a cardiac-type GIRK channel (Kir3.1/Kir3.4 heterotetramer24) and RGS425, 26.
In atrial myocytes (Fig. 1a,b) and oocytes expressing RGS4 (Fig. 1c,d), pilocarpine-induced GIRK currents 
during membrane hyperpolarization reached a peak (Ip) and then decreased to steady state by pulse-end (Is). 
This current decay suggests a desensitization of GIRK currents to pilocarpine at hyperpolarized potential in the 
presence of RGS4. The tau of current decay in the presence of 100 µM pilocarpine at –140 mV in RGS4-expressing 
oocytes was 0.47 ± 0.02 s (n = 6). This phenomenon was found to be due to the cessation of G-protein activation 
by modulation of GTP hydrolysis via RGS4 in our previous study using GTPγS18, a non-hydrolyzable analog of 
GTP. The current decay during hyperpolarization was not observed in the absence of RGS4 (Fig. 1e,f), suggesting 
that RGS4 is a crucial mediator in the hyperpolarization-induced desensitization of the GIRK channel. This sug-
gests that the mechanism of desensitization is an RGS4-mediated reduction in active G-proteins. Note that the 
term ‘desensitization’ does not imply an insensitivity of the GIRK channel itself.
In oocytes expressing RGS4, with 100 µM pilocarpine, Is during –140 mV pulses was smaller than Is at more 
positive potentials (Fig. 1c). However, the current-voltage (I-V) curve of Ip was linear at hyperpolarized poten-
tials, indicating GIRK currents are not yet desensitized immediately after hyperpolarization (Fig. 1d). The I-V 
curve of Is showed a different shape from that of Ip. The differences in current amplitude between Ip and Is indicate 
that desensitization increases as the membrane potential become more hyperpolarized (Fig. 1d). This phenom-
enon was not observed in the absence of RGS4 (Fig. 1e,f). The results demonstrate that hyperpolarization acts 
through RGS4 to desensitize GIRK channels to pilocarpine.
We next normalized the GIRK currents induced by different concentrations of pilocarpine with the same 
amplitude of Ip and then compared the level of Is in the presence and absence of RGS4 (Fig. 2a,b). With RGS4, we 
observed that a higher concentration (100 μM) of pilocarpine had more impact on the normalized Is level than 
a lower concentration (1 μM). The ratio Is/Ip decreased at high concentrations of pilocarpine and hyperpolar-
ized potentials in the presence of RGS4 (Fig. 2c), suggesting that RGS4 inhibits GIRK currents in a pilocarpine 
concentration-dependent manner. We then fitted the concentration-response curve of Is and Ip at −100 mV in 
the presence of RGS4 with the Hill equation (Fig. 2d). There was no considerable difference in the −logEC50 of Is 
and Ip (−logEC50 was 6.23 ± 0.12 M for Is; 6.11 ± 0.02 M for Ip), indicating that the receptor affinity of pilocarpine 
was not substantially changed by the presence of RGS4 modulation. We observed the maximal inhibitory effect 
of RGS4 modulation in the presence of saturated concentration of pilocarpine (100 μM). These results suggest 
that RGS4-GIRK response is voltage-dependent, and this depends on pilocarpine binding to the M2 muscarinic 
receptor.
Membrane potential rapidly modulates RGS4-mediated desensitization of M2 muscarinic 
receptor-GIRK signaling. We next characterized the kinetics of the voltage-dependent response. The time 
course of GIRK current recovery from desensitization was examined with two hyperpolarizing pulses protocol 
(−100 mV for 2 s) which were separated by an interpulse (0 mV) of different durations (0.1, 0.3, 0.5, 0.7 and 
0.9 s) (Fig. 3). Compared with the first hyperpolarizing pulse in the presence of RGS4, the pilocarpine-induced 
current showed a smaller Ip at the second hyperpolarizing pulse when the interpulse duration was 0.1 s (Fig. 3a). 
Prolonging the duration of interpulse to 0.5 s recovered the current amplitude of Ip. The tau of Ip recovery was 
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0.16 ± 0.01 s (n = 6) by exponential curve fitting. We did not observe hyperpolarization-induced desensitization 
in the absence of RGS4 (Fig. 3b). The results demonstrate that the M2 muscarinic receptor-GIRK signaling recov-
ers from hyperpolarization-induced RGS4-mediated desensitization very rapidly.
Mutations in the DRY motif of the M2 muscarinic receptor, instead of intracellular loop3, 
impaired RGS4 modulation of GIRK current mediated by pilocarpine. To reveal the mechanism 
which underlies the voltage-dependence of RGS4 modulation, we focused on the voltage-sensitive M2 muscarinic 
receptor. We examined several charged amino acid residues of the M2 muscarinic receptor which are highly con-
served in the rhodopsin-like GPCR family and may act as a voltage-sensor (Fig. 4a).
We first mutated charged residues D692.50 and D1033.32 (Fig. 4a,b), are in the transmembrane domains (TMs) 
of M2 muscarinic receptor and are relevant to voltage sensing and receptor activation4, 27, 28. Consistent with 
previous studies, we found that mutation of these residues to alanine (D69A and D103A) or asparagine (D69N 
and D103N) abolished ACh- and pilocarpine-induced GIRK currents in oocytes (Supplementary Fig. S1). This 
change may be due to the impairment of ligand binding in the mutation of D1033.32 or the reduced protein surface 
expression in the mutation of D692.50 4, 27.
We next mutated charged residues D1203.49 and R1213.50 located in the DRY motif of the M2 muscarinic 
receptor (Fig. 4a,b). Mutations that neutralized the charges of D1203.49 (D120N) or R1213.50 (R121N) sin-
gly, or both residues together (D120N/R121N), decreased the amplitude difference between the Ip and the Is 
of pilocarpine-evoked GIRK currents at −100 mV (Fig. 4d–f), as compared with that of wild-type (WT) M2 
muscarinic receptor (Fig. 4c) in the presence of RGS4. During a hyperpolarization pulse, the currents of oocytes 
expressing these three mutants only showed a modest decrease from Ip to Is in the presence of RGS4 (Fig. 4d–f, 
left panel). Such current decay during hyperpolarization was not seen in the absence of RGS4 (Fig. 4c–f, right 
panel). The ratios Is/Ip of the M2 muscarinic receptor mutants were significantly elevated compared with WT M2 
muscarinic receptor (0.83 ± 0.03 for D120N; 0.91 ± 0.02 for R121N; 0.79 ± 0.01 for D120N/R121N; 0.53 ± 0.04 
for WT, P ≤ 0.001 for each mutant when compared with WT) (Fig. 4g). This suggests that neutralization of 
Figure 1. Voltage-dependent response of pilocarpine-induced GIRK currents in rat atrial myocytes and 
Xenopus oocytes. (a) Pilocarpine (100 µM)-induced GIRK currents in rat atrial myocytes were recorded 
with a step pulse protocol as shown above the current traces. Basal currents were subtracted. (b) I-V curve 
of pilocarpine-induced GIRK currents in atrial myocytes. Ip (filled circles) indicates the peak current at an 
activated state of GIRK channel; Is (open circles) indicates the steady-state current at the end of the voltage 
pulse. Red arrows in a were used to reconstruct the I-V curve in b. (c–f) Pilocarpine (1, 10, 100 μM)-induced 
GIRK currents in Xenopus oocytes expressing M2 muscarinic receptor, Kir3.1/Kir3.4 with (c,d) and without 
(e,f) RGS4 were recorded with a step pulse protocol shown above. Basal currents were subtracted. Amplitudes of 
Ip and Is indicated by red arrows in c and e were used to reconstruct the I-V curve in d and f.
www.nature.com/scientificreports/
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D1203.49 or R1213.50 diminishes the hyperpolarization-induced desensitization of GIRK current by RGS4. To 
confirm whether mutations of D1203.49 and R1213.50 affect the pilocarpine-induced current, we calculated the 
concentration-response curves of these mutants. The concentration-response curves of D120N for pilocarpine- 
(Fig. 4h and Supplementary Fig. S2) and ACh-induced GIRK currents (Supplementary Fig. S3) were similar with 
WT, while the concentration-response curves of R121N for both pilocarpine and ACh were a rightward shift from 
that of WT. The 100 µM concentration of pilocarpine saturated current in all DRY mutants we tested. Although, 
as we shown in Fig. 2, the pilocarpine-bound M2 muscarinic receptor enhances RGS4-mediated desensitization 
of GIRK response at hyperpolarized potentials, the DRY motif mutants impaired this function. Therefore, the 
DRY motif of the M2 muscarinic receptor is an essential structural determinant of the voltage sensitivity of RGS4.
Since the intracellular loop 3 of the M2 muscarinic receptor is also involved in the voltage-dependence of 
ACh binding3, we examine the roles of the intracellular loop 3 in the voltage-dependence of RGS4 modulation 
of pilocarpine-induced GIRK current. Interestingly, we found that, in our oocyte expression system, the M2 
muscarinic receptor ELAAL mutant retained voltage-dependent response of pilocarpine-induced GIRK currents 
in the presence of RGS4 (Fig. 5a). The current of ELAAL mutant showed normal hyperpolarization-induced cur-
rent decay in the presence of RGS4. The Is/Ip of ELAAL mutant (0.55 ± 0.05, n = 6) was similar to that of WT M2 
muscarinic receptor (0.53 ± 0.04, n = 6) (Fig. 5b), suggesting that the N-terminal region of intracellular loop 3 is 
not essential for the voltage-dependence of RGS4 modulation. The current of ELAAL mutant fully recovered Ip 
Figure 2. Effects of RGS4 on modulation of GIRK current in a pilocarpine concentration-dependent manner. 
(a,b) Pilocarpine (1, 10, 100 μM)-induced GIRK currents in Xenopus oocytes expressing M2 muscarinic 
receptor, Kir3.1/Kir3.4 with (a) and without (b) RGS4 were recorded at −140 mV with the test pulse protocol 
shown above. The Ip evoked by different concentrations of pilocarpine (1, 10, 100 μM) were normalized to the 
same level (red dashed line). Different levels of Is in the presence of different pilocarpine concentrations were 
observed. (c) The ratio of Is to Ip (Is/Ip) at hyperpolarized potentials (−20 mV to −140 mV) in the applications 
of pilocarpine (1 µM, black circles; 10 µM, blue squares; 100 µM, green triangles) in oocytes expressing RGS4. 
Data are means ± s.e.m., n = 6–10. (d) Concentration-response curves of Is (filled circles) and Ip (open circles) 
of pilocarpine-induced GIRK current in the presence of RGS4 were fitted with the Hill equation. The maximal 
value of Ip of pilocarpine-induced GIRK current was normalized to 1. The –logEC50 was 6.23 ± 0.12 M for Is; 
6.11 ± 0.02 M for Ip. Data are means ± s.e.m., n = 3–6.
Figure 3. Effects of RGS4 on the recovery of GIRK currents from desensitization. (a,b) Pilocarpine (100 µM)-
induced GIRK currents in oocytes expressing M2 muscarinic receptor, Kir3.1/Kir3.4 with (a) and without  
(b) RGS4 were recorded with a protocol shown above. Current were recorded with two hyperpolarizing pulses 
from 0 mV to −100 mV for 2 s which were separated by an interpulse of 0 mV for a duration range of 0.1, 
0.3, 0.5, 0.7 and 0.9 s. The fully recovery of GIRK current from the desensitized state can be observed when 
interpulse (0 mV) duration is longer than 0.5 s. Time constant for the recovery was fitted with exponential curve 
and discussed in the result section.
www.nature.com/scientificreports/
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from the desensitization when the interpulse duration was 0.9 s, longer than with the WT M2 muscarinic recep-
tor (Fig. 5c). The tau for Ip recovery was 0.16 ± 0.01 s for WT and 0.34 ± 0.01 s for ELAAL, respectively (n = 6 
for each, P < 0.001 in Fig. 5d). The slow Ip recovery of ELAAL mutant from the hyperpolarization-induced 
desensitization suggests that this mutant takes a longer time to recover the GIRK current from RGS4 modula-
tion as compared with WT. The Is/Ip was, however, not influenced by mutation of KKDKK to ELAAL (Fig. 5b). 
Concentration-response curves of ELAAL mutant for pilocarpine (Fig. 5e and Supplementary Fig. S2) and ACh 
(Supplementary Fig. S3) were slightly rightward shifted as compared with that of WT. Taken together, the results 
indicate that the N-terminal region of intracellular loop 3 is not essential for voltage-dependence of RGS4.
Discussion
In the present study, we find that membrane potential modulates RGS4 function through the voltage-sensitive 
M2 muscarinic receptor. Hyperpolarization enhanced the RGS4-mediated inhibition of pilocarpine-induced 
GIRK currents in both rat atrial myocytes and Xenopus oocytes (Fig. 1). This phenomenon is dependent on the 
pilocarpine concentration (Figs 1 and 2). A previous study suggested that hyperpolarization induces a decrease 
in M2 muscarinic receptor affinity toward pilocarpine in cat atrial myocytes9. However, in the absence of RGS4, 
pilocarpine-induced GIRK current only showed a negligible decrease in current amplitude during hyperpolariza-
tion. Therefore, the hyperpolarization-induced desensitization of GIRK channel appears to be due to the increase 
in the capability of RGS4 modulation, not a decrease in ligand affinity.
Analyses of gating charge-movement and reporter fluorescent signal associated with M2 muscarinic recep-
tor have suggested that a voltage-induced conformational change in M2 muscarinic receptor occurs very rap-
idly, within 0.01 s3, 4, 12. This would precede the voltage-induced changes in RGS4 function. Our results showed 
that RGS4-mediated desensitization of GIRK currents recovers rapidly (tau of recovery time was about 0.16 s) at 
Figure 4. Charged residues in the DRY motif of the M2 muscarinic receptor contribute to the voltage-
dependent response of GIRK currents. (a) Alignment of amino acids of different species of M2 muscarinic 
receptors and other human rhodopsin-like GPCRs. Triangles indicate the position of charged residues D692.50, 
D1033.32, D1203.49 and R1213.50. (b) M2 muscarinic receptor model was based on the crystal structure (PDB 
accession 4MQS)27. The charged residues that we investigated in this study are colored. (c–f) Pilocarpine 
(100 µM)-induced GIRK currents in oocytes expressing the WT M2 muscarinic receptor (c) or mutants D120N 
(d), R121N (e) and D120N/R121N (f) with (left panels) and without (right panels) RGS4 were recorded at 
−100 mV as shown above. (g) The ratio of Is to Ip (Is/Ip) of pilocarpine-induced GIRK current at −100 mV 
in oocytes expressing M2 muscarinic receptor WT and mutants. (h) Concentration-response curves of 
pilocarpine-induced GIRK current were fitted with the Hill equation. The maximal value of pilocarpine-
induced GIRK current was normalized to 1. The −log EC50 was 6.51 ± 0.01 for WT; 6.81 ± 0.01 for D120N; 
5.66 ± 0.01 for R121N; 6.50 ± 0.01 for D120N/R121N. Data in g and h are means ± s.e.m., n = 6–8. ***Indicates 
a statistically significant difference (P ≤ 0.001).
www.nature.com/scientificreports/
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holding membrane potential (Fig. 3), and this event would follow the receptor conformational change mediated 
by voltage change.
We showed that D1203.49 or R1213.50 in the DRY motif of M2 muscarinic receptor contribute to the 
voltage-dependence of RGS4 modulation of GIRK current. These charged residues are part of the underlying 
mechanism that enhances the capability of RGS4 modulation at hyperpolarized potentials (Fig. 4). This result 
indicates that the voltage-dependence of RGS4 is derived from the M2 muscarinic receptor. One possible mode 
of action for D1203.49 and R1213.50 is that these residues act as part of voltage sensors in the receptor for sensing 
membrane potential. Another possible mode is that these residues are required for its interaction with RGS4 
because DRY motif is located on the cytosolic side of the plasma membrane. However, it is most likely that 
these charged residues support the pathway that mediates voltage-dependent conformational change of the M2 
muscarinic receptor because these charged residues form a part of charge-charge interaction which stabilizes the 
receptor conformation14. These charged residues respectively interact with other residues located in the TM2 
and TM6 as well14, 16, 27. Once the negative charge of D1203.49 is neutralized, the converse R1213.50 is probably free 
to move to find another ionic partner29 and vice versa. Therefore, neutralization of both D1203.49 and R1213.50 
or only one of them disturbs the balance of charge-charge interaction within receptor and thus altering the 
voltage-sensitivity.
Other charged residues of the M2 muscarinic receptor are relevant to the voltage sensing, including D692.50 
and D1033.32 4. However, mutations of D692.50 or D1033.32 appear to reduce both receptor expression and agonist 
Figure 5. Effects of mutations in the intracellular loop 3 of M2 muscarinic receptor on the voltage-dependent 
response of GIRK currents. (a) Pilocarpine (100 µM)-induced GIRK currents in oocytes expressing M2 
muscarinic receptor mutant ELAAL with (left panels) and without (right panels) RGS4 were recorded at 
−100 mV as shown above. (b) The ratio of Is to Ip (Is/Ip) of M2 muscarinic receptor WT and ELAAL at –100 mV 
in the presence of pilocarpine (100 µM). (c) Recoveries of pilocarpine (100 µM)-induced GIRK currents from 
hyperpolarization-mediated desensitization of channels in oocytes expressing WT and ELAAL M2 muscarinic 
receptors were recorded with a protocol shown above the current traces. (d) The time constant (tau) of Ip 
recovery times in c were calculated with exponential curve fitting. (e) Concentration-response curves of 
pilocarpine-induced GIRK currents were fitted with the Hill equation. The maximal value of pilocarpine-
induced GIRK current was normalized to 1. The −logEC50 was 6.51 ± 0.02 for WT; 6.15 ± 0.02 for ELAAL. Data 
in b, d and e are means ± s.e.m., n = 6. ***Indicates a statistically significant difference (P < 0.001).
www.nature.com/scientificreports/
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binding4, 27, 28. These changes may be the reason why we could not observe agonist-induced currents and limits 
our evaluation of their roles to the present experimental design.
Membrane potential regulates the binding and dissociation of ACh with the M2 muscarinic receptor through 
the N-terminal region of the intracellular loop 33, 12, 30. In the present study, we showed that replacing the 
N-terminal region of the intracellular loop 3 of the M2 muscarinic receptor (residues KKDKK) to ELAAL decel-
erates the recovery of the voltage-induced change in pilocarpine-induced GIRK current as compared with WT 
in the presence of RGS4 (Fig. 5). Several studies have demonstrated that replacing intracellular loop 3 of the M2 
muscarinic receptor with the corresponding sequence from the M1 muscarinic receptor or β1-adrenergic recep-
tor changes the specificity for different subtypes of Gα and changes the ligand-mediated activation of G-protein 
signaling31–33. Therefore, the affinity of the ELAAL mutant for the Gi/o type of Gα should be different from WT 
M2 muscarinic receptor. The Gi/o-RGS4 complex may be associated with intracellular loop 3 of the ELAAL 
mutant in a less stable state, as compared with WT, and thus decelerates the recovery of G-protein signaling from 
RGS4-mediated regulation.
Recent studies demonstrated that the voltage-dependence of the M1 muscarinic receptor toward ACh binding 
is opposite to the M2 muscarinic receptor2 and replacing intracellular loop 3 of the M2 muscarinic receptor with 
that of M1 muscarinic receptor gives the mutated receptor the voltage-dependence of the M1 muscarinic receptor3. 
However, our results demonstrated that the ELAAL mutant retains the voltage-dependence of RGS4 function. 
This suggests that this region is responsible for the voltage-regulated coupling of the GPCR to its G-protein30, and 
this pathway is independent to the voltage-dependence of RGS4 modulation on G-protein signal. Taken together, 
both the positive pathway (agonist-induced activation) and the negative pathway (RGS4-mediated inhibition) of 
G-protein signaling are controlled by voltage via different motif at M2 muscarinic receptor, and thus modulating 
the receptor communication with downstream effectors, Gi/o and RGS4.
As several RGS-associated GPCRs have been identified34–37, further research will be required to fully under-
stand the interaction between the receptor and RGS protein, which underlies the voltage-dependent modulation 
of RGS in regulating downstream GPCR signaling. The C-terminal tail of GPCR proteins is a candidate region for 
mediating the association between RGS proteins and GPCRs38, 39.
In the present study, we showed that membrane potential modulates RGS4 function through the 
voltage-sensitive M2 muscarinic receptor. Especially at hyperpolarized potentials, pilocarpine, which categorized 
as a “partial agonist” may, in fact, stabilize a receptor conformation which leads to relatively high GTP hydrolysis 
activity as compared to that of a full agonist. This study sheds light on the multimodal functions of the M2 mus-
carinic receptor in both signal perception and transduction.
Methods
Animals and cell preparations. Animal experiments were performed in accordance with the guidelines 
for the use of laboratory animals of Osaka University Graduate School of Medicine. The experimental protocol 
was approved by the Institutional Animal Care and Use Committee and the Animal Experiments Committee 
of Osaka University. Single atrial myocytes were enzymatically isolated from hearts of adult male Wistar rats 
(200–300 g) as previously described40 and maintained in KB solution containing 10 mM taurine, 10 mM oxalic 
acid, 70 mM glutamic acid, 25 mM KCl, 10 mM KH2PO4, 0.5 mM EGTA, 11 mM glucose and 10 mM HEPES (pH 
7.3 with KOH, 295–300 mOsm L−1). Freshly isolated cells were used in patch clamp experiments on the day.
The cRNA of porcine M2 muscarinic receptor (80 ng oocyte−1), mouse Kir3.1 (8 ng oocyte−1), rat Kir3.4 (8 ng 
oocyte−1) and rat RGS4 (160 ng oocyte−1) were used in this study. The porcine M2 muscarinic receptor was 
encoded on pSP64T plasmid. Point mutations in the M2 muscarinic receptor were constructed by PCR mutagen-
esis and verified by sequencing. The positions of amino acid residues of M2 muscarinic receptor are indicated 
by their generic number according to the Ballesteros–Weinstein nomenclature41. Complementary RNAs were 
transcribed from the cDNA by mMessage mMachine kit (Ambion). Xenopus laevis oocytes were prepared and 
injected with cRNA as described previously42. After injection, oocytes were incubated at 18 °C in ND96 solution 
containing 96 mM NaCl, 2 mM KCl, 1.8 mM CaCl2, 1 mM MgCl2 and 5 mM HEPES (pH 7.6 with NaOH) and 
supplemented with gentamicin (50 µg ml−1). Currents were recorded 3–5 days after the cRNA injection.
Electrophysiological recording. Voltage-clamped currents of atrial myocytes were recorded in the 
whole-cell configuration by a patch-clamp amplifier (EPC10, HEKA Electronics, Lambrecht, Germany) at room 
temperature. Data were low-pass-filtered at 1 kHz (–3 dB) by an eight-pole Bessel filter, sampled at 5 kHz, and 
analyzed offline with PatchMaster (HEKA Electronics) and FitMaster (HEKA Electronics). Myocytes were 
recorded in a bath solution containing 115 mM NaCl, 20 mM KCl, 1.8 mM CaCl2, 0.53 mM MgCl2, 5.5 mM glu-
cose and 5.5 mM HEPES (pH 7.4 with NaOH). The tip resistance of glass electrodes was 2–5 MΩ when filled with 
the pipette solution containing 150 mM KCl, 5 mM EGTA, 1 mM MgCl2, 3 mM K2ATP, 0.1 mM Na2GTP and 
5 mM HEPES (pH 7.3 with KOH).
For oocytes, membrane currents were recorded using the two-electrode voltage clamp by a GeneClamp 
500 amplifier (Molecular Devices, Sunnyvale, CA, USA) at room temperature. Data were reproduced and 
analyzed with pCLAMP 10 (Molecular Devices) and Clampfit 10.2 (Molecular Devices). The bath solution 
contained: 90 mM KCl, 3 mM MgCl2, 0.15 mM niflumic acid and 5 mM HEPES (pH 7.4 with KOH). The tip 
resistance of glass electrodes was 0.4–1.5 MΩ when filled with the 3 M KCl pipette solution. Pilicarpine (0.001–
300 μM)-induced currents and ACh (0.0001–10 μM)-induced currents were obtained by digitally subtracting the 
basal currents. The concentration-response curve were measured by sequential application of pilocarpine and 
ACh in bath solution for 30–60 s at each concentration when current amplitude reached a stable level as shown 
in Supplementary Figs S2 and S3. 100 μM Pilocarpine-induced current could be washed out within 1–2 min. 
Concentration-response curve were fitted by Hill equation with SigmaPlot 12 (Hulinks).
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Data statistics. Data statistical analysis was performed with SigmaPlot 12 (Hulinks). Results are shown as 
mean ± s.e.m. from n cells. Statistical differences between each group were evaluated by Tukey’s test. Values of 
P < 0.05 were judged statistically significant. *, ** and *** indicate values of P < 0.05, 0.01 and 0.001, respectively.
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